换一批
换一批Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia.
作者：
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);儿童(Child);临床试验(主题)(Clinical Trials as Topic);计算机系统(Computer Systems);DNA, 互补(DNA, Complementary);无病生存(Disease-Free Survival);药物监测(Drug Monitoring);女(雌)性(Female);随访研究(Follow-Up Studies);基因剂量(Gene Dosage);人类(Humans);伊达比星(Idarubicin);Kaplan-Meiers评估(Kaplan-Meier Estimate);白血病, 早幼粒细胞, 急性(Leukemia, Promyelocytic, Acute);白细胞计数(Leukocyte Count);男(雄)性(Male);中年人(Middle Aged);多中心研究(主题)(Multicenter Studies as Topic);肿瘤, 残余(Neoplasm, Residual);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);聚合酶链反应(Polymerase Chain Reaction);试验预期值(Predictive Value of Tests);RNA, 信使(RNA, Messenger);RNA, 肿瘤(RNA, Neoplasm);复发(Recurrence);缓解诱导(Remission Induction);危险性评估(Risk Assessment);挽救疗法(Salvage Therapy);敏感性与特异性(Sensitivity and Specificity);存活率分析(Survival Analysis);维甲酸(Tretinoin)
DOI
10.3324/haematol.10734
PMID
17339180
发布时间
2019-06-08
- 浏览53
Haematologica
315-22页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
